Disclosures for "Enabling Subcutaneous Dosing of Gantenerumab in Alzheimer’s Disease")
-
Dr. Bittner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.. Dr. Bittner has stock in F. Hoffmann-La Roche Ltd..
-
Dr. Schwab has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Schwab has stock in F. Hoffmann-La Roche Ltd..
-
Mrs. Portron has nothing to disclose.
-
Dominik Lott has received personal compensation for serving as an employee of Roche. Dominik Lott has received stock or an ownership interest from Idorsia Pharmaceuticals.
-
Frank Boess has received personal compensation for serving as an employee of F.Hoffmann-LaRoche. Frank Boess has stock in F. Hoffmann-La Roche. Frank Boess has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Kohler has nothing to disclose.
-
Mr. Wojtowicz has received personal compensation for serving as an employee of F. Hoffmann-La Roche. Mr. Wojtowicz has stock in F. Hoffmann-La Roche.
-
Carsten Hofmann has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Carsten Hofmann has received stock or an ownership interest from F. Hoffmann-La Roche Ltd.